Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 mu g (nine breaths) four times daily Article

Open Access Industry Collaboration

cited authors

  • Shapiro, Shelley; Mandras, Stacy; Restrepo-Jaramillo, Ricardo; Shen, Eric; Broderick, Meredith; Rao, Youlan; Lee, Dasom; Nelsen, Andrew C.

authors

Publication Date

  • October 1, 2021

webpage

published in

category

keywords

  • Tyvaso
  • prostacyclins
  • pulmonary arterial hypertension

volume

  • 11

issue

  • 4